Related Experiment Video

Updated: Aug 10, 2026

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
08:54

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System

Published on: March 20, 2016

Transformation of mammalian cells by constitutively active MAP kinase kinase

S J Mansour1, W T Matten, A S Hermann

  • 1Department of Chemistry and Biochemistry, University of Colorado, Boulder 80309.

Science (New York, N.Y.)
|August 12, 1994
PubMed

Insights

Constitutively active Mitogen-activated protein kinase kinase (MAPKK) mutants promoted cell transformation. These findings suggest MAPKK activation is sufficient for oncogenesis, impacting cancer research.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Signal transduction pathways

Background:

  • Mitogen-activated protein (MAP) kinase kinase (MAPKK) is crucial in signal transduction pathways regulating cellular responses to growth and differentiation factors.
  • Oncogenes like ras, src, raf, and mos are hypothesized to cause cell transformation by sustaining MAPKK activation.

Purpose of the Study:

  • To investigate if sustained activation of MAPKK is sufficient to induce cell transformation.
  • To test the hypothesis that oncogenic transformation involves prolonged activation of MAPKK and downstream signaling components.

Main Methods:

  • Engineered constitutively active MAPKK mutants with significantly elevated basal activity (up to 400-fold higher than wild-type).
  • Expressed these mutants in mammalian cells.
  • Assessed AP-1-regulated transcription, soft agar colony formation, and tumorigenicity in nude mice.

Main Results:

  • Expression of constitutively active MAPKK mutants led to activation of AP-1-regulated transcription.
  • Cells expressing these mutants exhibited transformed foci formation.
  • These cells demonstrated efficient growth in soft agar and high tumorigenicity in nude mice.

Conclusions:

  • Constitutive activation of MAPKK is sufficient to promote cell transformation.
  • This study provides direct evidence linking MAPKK hyperactivation to oncogenesis.
  • Findings have implications for understanding cancer development and identifying therapeutic targets.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...